Attached files
| file | filename |
|---|---|
| 10-Q - NEOGENOMICS INC | v182637_10q.htm |
| EX-31.3 - NEOGENOMICS INC | v182637_ex31-3.htm |
| EX-31.1 - NEOGENOMICS INC | v182637_ex31-1.htm |
| EX-31.2 - NEOGENOMICS INC | v182637_ex31-2.htm |
| EX-10.46 - NEOGENOMICS INC | v182637_ex10-46.htm |
| EX-10.45 - NEOGENOMICS INC | v182637_ex10-45.htm |
| EX-10.44 - NEOGENOMICS INC | v182637_ex10-44.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report of NeoGenomics, Inc. (the “Company”) on
Form 10-Q for the three months ended March 31, 2010 as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), each of the
undersigned, in the capacities and on the dates indicated below, hereby certify
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to his knowledge:
1. The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
2. The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
|
Date:
May 4, 2010
|
/s/ Douglas M.
VanOort
|
|
Douglas
M. VanOort
|
|
|
Chairman
and Chief Executive
|
|
|
Officer
|
|
|
Date:
May 4, 2010
|
/s/ George
Cardoza
|
|
George
Cardoza
|
|
|
Chief
Financial Officer
|
|
|
Date:
May 4, 2010
|
/s/ Jerome J.
Dvonch
|
|
Jerome
J. Dvonch
|
|
|
Director
of Finance and Principal Accounting
|
|
|
Officer
|
The
foregoing certification is being furnished solely to accompany the Report
pursuant to 18 U.S.C. § 1350, and is not being filed for purposes of Section 18
of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before or
after the date hereof, regardless of any general incorporation language in such
filing. A signed original of this written statement required by Section 906, or
other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.